Altrinsic Global Advisors’s Fate Therapeutics FATE Stock Holding History

Altrinsic Global Advisors’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-27,000	Closed	-$1.58M	–	59
2021 Q4	$1.58M	Hold	27,000	–	–	0.05%	62
2021 Q3	$1.6M	Sell	27,000 -3,000	-10%	-$235K	0.05%	67
2021 Q2	$2.6M	Hold	30,000	–	–	0.08%	59
2021 Q1	$2.47M	Sell	30,000 -10,000	-25%	-$958K	0.08%	60
2020 Q4	$3.64M	Sell	40,000 -20,000	-33%	-$1.24M	0.12%	48
2020 Q3	$2.4M	Hold	60,000	–	–	0.1%	53
2020 Q2	$2.06M	Hold	60,000	–	–	0.09%	55
2020 Q1	$1.33M	Sell	60,000 -10,000	-14%	-$253K	0.07%	60
2019 Q4	$1.37M	Hold	70,000	–	–	0.06%	61
2019 Q3	$1.09M	Hold	70,000	–	–	0.05%	68
2019 Q2	$1.42M	Hold	70,000	–	–	0.07%	66
2019 Q1	$1.23M	Hold	70,000	–	–	0.06%	72
2018 Q4	$898K	Hold	70,000	–	–	0.04%	68
2018 Q3	$1.14M	Buy	70,000 +20,000	+40%	+$237K	0.05%	72
2018 Q2	$567K	Buy	+50,000	New	+$551K	0.02%	79

Other funds holding FATE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return